Benalmádena introduces two drugs that slow early Alzheimer's
Vithas Xanit Hospital in Benalmádena adds donanemab and lecanemab, two intravenous drugs that slow early Alzheimer's, without public funding.
Latest Alzheimer's news
6 articles
CEAFA's president, Mariló Almagro, demands funding for lecanemab and donanemab, which slow Alzheimer's by 18 months. Women bear 82% of care.
Vithas Xanit Hospital in Benalmádena adds donanemab and lecanemab, two intravenous drugs that slow early Alzheimer's, without public funding.

Andalusia has made significant progress in early Alzheimer diagnosis by incorporating specific blood biomarkers, moving towards less invasive medical care.
Geriatrician Rosa López Mongil and nurse Sister Guadalupe de la Cruz create 'Entrenando Día a Día 2.0', a method endorsed by SEN and CEAFA to delay dementia.

A team of researchers from Málaga has found that D-chiro-inositol could improve memory in Alzheimer's models, offering new research avenues.
Pedro Serrano Castro, head of Neurology at Málaga Regional Hospital, calls for funding for lecanemab and donanemab, new Alzheimer's drugs, and warns of access delays.